Severity
Low
FDA Drug recall · Reported April 24, 2019
Defective container: Ineffective seal between the cap and jar of the affected product.
Estee Lauder Inc recalled Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15, packaged in a light gr… - a low-severity action.
Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15, packaged in a light gr… was recalled by Estee Lauder Inc in April 24, 2019. Reason: Defective container: Ineffective seal between the cap and jar of the affected product.. Check the official notice for the remedy. Verify recall #D-1132-2019 with the FDA Drug before acting.
The recall
Estee Lauder Inc issued this low-severity FDA Drug recall-Defective container: Ineffective seal between the cap and jar of the affected product..
Sourced from official FDA Drug enforcement records. Verify recall #D-1132-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1132-2019) was formally reported on April 24, 2019, with the manufacturer initiating the action on March 15, 2019. It is classified under Low severity (Class III), with a current status of Terminated. Estee Lauder Inc is listed as the recalling firm, operating out of New York, NY. Federal records list the affected scope as 14490 jars.
The documented reason for this recall is: Defective container: Ineffective seal between the cap and jar of the affected product. Distribution data in the federal record shows the product reached: U.S.A. Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 1,360 cosmetics & personal care recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
14490 jars
Related Recalls
6
3 from same agency
Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15, packaged in a light green folding carton containing a 50 mL silver jar with a silver cap, Clinique Laboratories, Dist. New York, NY 10022
Defective container: Ineffective seal between the cap and jar of the affected product.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-1132-2019 |
| Date reported | April 24, 2019 |
| Date initiated | March 15, 2019 |
| Recalling firm | Estee Lauder Inc |
| Firm location | New York, NY |
| Affected scope | 14490 jars |
| Distribution | U.S.A. Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-06-04
PS Seasoning & Spices, Inc. · 2026-05-27
Fontana Flavors, Inc · 2026-05-27
Wisconsin Pharmacal Company · 2026-05-27
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-04-22
Compare this recall with Tiny Land Children's Play Tents Recalled Due to Risk of Inj… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 24, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.